osteoarthritis - Nursing Case Study

Pathophysiology

• Primary mechanism: Cartilage degradation - Osteoarthritis primarily involves the breakdown of articular cartilage due to an imbalance between cartilage synthesis and degradation. This occurs when chondrocytes fail to maintain the extracellular matrix, leading to cartilage thinning and loss of joint cushioning.

• Secondary mechanism: Subchondral bone sclerosis - As cartilage deteriorates, increased stress is transferred to the subchondral bone, causing it to become denser and sclerotic. This adaptation leads to decreased shock absorption and further joint stress.

• Key complication: Osteophyte formation - In response to cartilage loss and altered joint mechanics, the body may form osteophytes or bone spurs. These bony projections can limit joint mobility and contribute to pain and stiffness, exacerbating functional impairment.

Patient Profile

Demographics:

62-year-old female, retired nurse

History:

• Key past medical history: Osteoarthritis diagnosed 5 years ago, hypertension, type 2 diabetes

• Current medications: Acetaminophen, Metformin, Lisinopril, Glucosamine supplements

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased joint pain and stiffness, particularly in the knees and hips

• Key symptoms: Swelling in the knees, reduced range of motion, occasional crepitus in the joints, fatigue

• Vital signs: Blood pressure 150/92 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

As the patient's case unfolds, a new complication emerges: increased swelling and warmth over the right knee, along with an acute exacerbation of pain. Upon initial assessment, additional findings include an elevated heart rate of 98 bpm and a slight increase in blood pressure to 158/94 mmHg. The patient reports a sharp, localized pain that differs from her typical osteoarthritic discomfort, which raises concerns for a potential secondary condition such as joint effusion or an inflammatory process like a synovitis flare-up. The nurse notes that the swelling has become more pronounced compared to previous visits, indicating a possible progression or complication associated with the osteoarthritis.

In light of these developments, the healthcare team orders a series of diagnostic tests to further evaluate the underlying causes of the patient's symptoms. An X-ray of the right knee reveals increased joint space narrowing and the presence of small osteophytes, consistent with advanced osteoarthritis. However, an ultrasound of the knee joint shows evidence of a moderate effusion and signs of synovial thickening. These findings suggest the possibility of secondary synovitis, which may be contributing to the patient's increased pain and swelling. Lab tests reveal a slightly elevated C-reactive protein (CRP) level, indicating inflammation, although white blood cell count remains within normal limits.

These new diagnostic results prompt the team to consider adjusting the patient's management plan. The focus shifts to reducing inflammation and managing pain more effectively. The healthcare provider considers introducing non-steroidal anti-inflammatory drugs (NSAIDs) while closely monitoring for potential gastrointestinal side effects, given the patient's history of hypertension and diabetes. The nurse discusses lifestyle modifications and physical therapy options with the patient to improve joint function and reduce stress on the affected areas. This plan aims to address the current symptoms while also considering the patient's overall health and chronic conditions, ensuring a comprehensive approach to her osteoarthritis management.

Section 2

In response to the newly adjusted management plan, the patient begins a regimen of non-steroidal anti-inflammatory drugs (NSAIDs) to address the inflammation and pain in her right knee. Within a few days, she reports a mild improvement in her pain levels, describing them as more manageable than before. However, she also experiences some gastrointestinal discomfort, characterized by mild nausea and occasional heartburn, prompting the healthcare team to implement protective measures such as prescribing a proton pump inhibitor (PPI) to mitigate potential gastrointestinal side effects from the NSAIDs.

Clinically, the patient's vital signs show a slight improvement, with her blood pressure stabilizing at 150/90 mmHg and heart rate reducing to 92 bpm. These changes suggest a positive response to the interventions, though the healthcare team remains vigilant due to her history of hypertension and diabetes. The swelling in her right knee shows a modest reduction, but the warmth and localized sharp pain persist, indicating that while the inflammation is being managed, the underlying issues may not be fully resolved.

As the team continues to monitor her progress, they emphasize the importance of lifestyle modifications and physical therapy. The patient is encouraged to adopt a low-impact exercise regimen tailored to her abilities, focusing on strengthening the muscles around her knee to support joint function. Additionally, dietary adjustments are discussed to aid in weight management and reduce joint stress. These interventions are designed to provide a holistic approach to managing her osteoarthritis while also addressing the acute symptoms of synovitis. The team arranges for follow-up assessments to evaluate the effectiveness of the treatment plan and make any necessary adjustments, preparing for potential new challenges that may arise in her ongoing care.

Section 3

A few weeks into the adjusted management plan, the patient attends a scheduled follow-up appointment. During this visit, the healthcare team conducts a comprehensive assessment to evaluate her response to the interventions and identify any emerging complications. The patient reports that her gastrointestinal symptoms have subsided since starting the proton pump inhibitor, and she continues to experience manageable pain levels in her right knee. However, she mentions a recent onset of fatigue and occasional dizziness, which she attributes to her busy lifestyle and lack of rest.

The clinical team notes some concerning changes in the patient's laboratory results. Blood tests reveal a slight drop in hemoglobin levels, suggesting the possibility of mild anemia, which could explain her fatigue and dizziness. Additionally, her renal function tests indicate a mild elevation in serum creatinine and blood urea nitrogen (BUN), raising concerns about potential NSAID-related nephrotoxicity. These findings prompt the team to review her medication regimen and consider alternative pain management strategies to minimize kidney strain.

In response to these developments, the healthcare team prioritizes addressing the anemia and potential renal issues. They recommend dietary adjustments to increase her intake of iron-rich foods and advise her to maintain adequate hydration. The patient's NSAID dosage is reevaluated, and a discussion about incorporating acetaminophen or topical analgesics as adjuncts is initiated. The team arranges for more frequent monitoring of her renal function and hemoglobin levels, emphasizing the importance of early detection and intervention to prevent further complications. As the patient navigates these new challenges, the team remains committed to a balanced approach that prioritizes both symptom management and overall health maintenance.

Section 4

A month after the revised management plan was implemented, the patient returns for another follow-up appointment. During this visit, the healthcare team conducts a thorough assessment and notes some changes in the patient's condition. While her gastrointestinal symptoms remain under control, the patient reports persistent fatigue and occasional dizziness, which are now accompanied by new symptoms of shortness of breath upon exertion and palpitations. These symptoms prompt the clinical team to perform a more detailed cardiovascular and respiratory examination.

Vital signs reveal a blood pressure of 130/85 mmHg, heart rate of 92 beats per minute with occasional irregularities, respiratory rate of 20 breaths per minute, and oxygen saturation at 95% on room air. The patient's hemoglobin level has decreased further to 10.2 g/dL from the previous 11.5 g/dL, consistent with worsening anemia, and her renal function tests show a slight increase in serum creatinine to 1.3 mg/dL and BUN to 26 mg/dL. Given these findings, the team becomes concerned about the potential development of iron deficiency anemia and the impact of her medication regimen on renal function.

The healthcare team decides to initiate oral iron supplementation to address the anemia while continuing to monitor the patient closely for any adverse effects. The patient's NSAID usage is further scrutinized, and the team considers a trial of a COX-2 inhibitor, which might offer pain relief with potentially less renal impact. Additionally, a referral to a cardiologist is recommended to evaluate the new cardiac symptoms and ensure that they are not indicative of a more serious underlying condition. This comprehensive approach aims to balance symptom management with the prevention of further complications, as the team remains vigilant in adapting the management plan to the patient's evolving needs.

Section 5

As the patient returns for a follow-up appointment two weeks after the initiation of oral iron supplementation and the trial of a COX-2 inhibitor, the healthcare team notes several changes in her condition. The patient reports a slight improvement in her energy levels, but she continues to experience episodes of dizziness and palpitations, particularly when engaging in physical activity. Additionally, she mentions new-onset swelling in her lower extremities, which raises concerns about fluid retention or potential cardiac issues.

The clinical team conducts a thorough physical examination and orders additional diagnostic tests to further evaluate these symptoms. Upon examination, mild pitting edema is observed in the patient's ankles, and auscultation reveals a faint systolic murmur that was not previously noted. Laboratory results show a modest improvement in hemoglobin levels to 10.8 g/dL, indicating a partial response to iron supplementation. However, there is a concerning rise in serum creatinine to 1.5 mg/dL and BUN to 30 mg/dL, suggesting that renal function may be further compromised.

Given these findings, the healthcare team collaborates with the cardiologist to investigate the possibility of developing heart failure or other cardiovascular complications that could be contributing to the patient's symptoms. An echocardiogram is ordered to assess cardiac function and structure, while adjustments in medication are considered to better manage her renal health. The team remains focused on integrating these findings into a cohesive management plan that addresses both the patient's osteoarthritis and her emerging cardiovascular and renal issues, emphasizing the importance of a multidisciplinary approach to prevent further complications and enhance her overall quality of life.